BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 2588751)

  • 1. Diphenylcyclopropenone-induced vitiligo in a patient with alopecia universalis.
    Riad H; Mannai HA; Mansour K; Qaatri KA; Dosari SA; Obaidaly AA; Sultan E
    Case Rep Dermatol; 2013; 5(2):225-31. PubMed ID: 24019775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy.
    Desai DD; Buontempo MG; Nohria A; Alhanshali L; Lo Sicco K; Shapiro J
    JAAD Case Rep; 2024 Jun; 48():88-89. PubMed ID: 38783932
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of cyclopropenone derivatives as promising bioactive molecules.
    Jin S; He Z; Du Y; Jin G; Wang K; Yang F; Zhang J
    Bioorg Med Chem Lett; 2024 Jun; 109():129845. PubMed ID: 38852789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of alopecia areata with diphenylcyclopropenone].
    Ochsendorf FR; Mitrou G; Milbradt R
    Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks].
    Lutz G; Kreysel HW
    Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Shapiro J
    Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.